Joop C. van Oene

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers

Aernout D. van Haarst, Gerben A. E. van't Klooster, Joop van Gerven et al. · Clinical Pharmacology & Therapeutics · 1998 · 151 citations

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

Alistair Burns, Roberto Bernabei, Roger Bullock et al. · The Lancet Neurology · 2008 · 150 citations

Neurodegenerative Diseases, Severe Alzheimer, Alzheimer's Disease +10

Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation

Cornelius E. J. Sloots, Alexander C. Poen, René Kerstens et al. · Alimentary Pharmacology & Therapeutics · 2002 · 95 citations

[125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor

A Sidhu, Joop C. van Oene, Penelope A. Dandridge et al. · European Journal of Pharmacology · 1986 · 71 citations

Molecular Pharmacology, Medicine, D-1 Dopamine Receptor +8

The D1 dopamine receptor: new perspectives

John W. Kebabian, Takashi Agui, Joop C. van Oene et al. · Trends in Pharmacological Sciences · 1986 · 70 citations

Psychiatry, Functional Selectivity, Medicine +5